Showing results (801-810 of 1,291) with videos related to
Sort By:
Pageof 130
Current HIV Research|October 20, 2017
Construction and Production of HIV-VLP Harboring MPER-V3 for Potential Vaccine StudyFatemeh Tohidi, Seyed Mehdi Sadat, Azam Bolhassani, et al.Current HIV Research|November 19, 2015
Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced MenAmandine Gagneux-Brunon, Dorsaf Nasri, Rachel Terrasse, et al.Current HIV Research|November 28, 2017
SIV Coreceptor Specificity in Natural and Non-Natural Host Infection: Implications for Cell Targeting and Differential Outcomes from InfectionKatherine S Wetzel, Sarah T C Elliott, Ronald G CollmanCurrent HIV Research|December 7, 2017
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected PatientsIsabella Bon, Leonardo Calza, Giuseppina Musumeci, et al.Current HIV Research|November 23, 2017
Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four YearsEvangelia Kostaki, Gkikas Magiorkinis, Mina Psichogiou, et al.Current HIV Research|February 23, 2018
Comparative Genetic Variability in HIV-1 Subtype C vpu Gene in Early Age Groups of InfantsUma Sharma, Poonam Gupta, Sunil Gupta, et al.Current HIV Research|February 23, 2018
Investigating HIV-Human Interaction Networks to Unravel Pathogenic Mechanism for Drug Discovery: A Systems Biology ApproachCheng-Wei Li, Bor-Sen ChenCurrent HIV Research|December 7, 2018
M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell LinesBahareh Rostami, Shiva Irani, Azam Bolhassani, et al.Current HIV Research|May 16, 2009
HIV-1 plasma variants encoding truncated reverse transcriptase (RT) in a patient with high RT-specific CD8+ memory T-cell responseStefania Paolucci, Andrea Foli, Roberto Gulminetti, et al.Current HIV Research|May 16, 2009
Reversal of major genotypic tipranavir mutations under long-term treatment with tipranavir/ritonavir itself with very limited optimized background, during deep salvage antiretroviral therapySergio Sabbatani, Roberto Manfredi, Ciro Fulgaro, et al.Pageof 130